Pharmena S.A. (PHR) — Capital Reinvestment Ratio
Pharmena S.A. (PHR) has a Capital Reinvestment Ratio of 0.00x as of June 2023, meaning it reinvests 0% of its operating cash flow (zł44.83 Million) in capital expenditures (zł131.00K). Check PHR tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pharmena S.A. Capital Reinvestment Ratio (2011–2023)
This chart tracks Pharmena S.A.'s Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see PHR cash flow conversion.
Annual Capital Reinvestment Ratio for Pharmena S.A. (2011–2023)
Year-by-year Capital Reinvestment Ratio for Pharmena S.A. from 2011 to 2023. See how much free cash does Pharmena S.A. generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | zł33.03 Million | zł314.00K | ▼ -92.3% |
| 2022 | 0.12x | zł1.82 Million | zł226.00K | ▲ +0.6% |
| 2018 | 0.12x | zł3.61 Million | zł446.00K | ▼ -61.2% |
| 2017 | 0.32x | zł619.00K | zł197.00K | ▲ +208.1% |
| 2011 | 0.10x | zł666.91K | zł68.89K | — |